Melissa L. Gillaspy

A simple method for the formation of cyclopropylamines: the first synthesis of tricyclopropylamine

Melissa L. Gillaspy, Bruce A. Lefker, William A. Hada et al. · Tetrahedron Letters · 1995 · 53 citations

First Synthesis, Engineering, Heterocyclic +7

Discovery of N-benzyl-2-[(4S)-4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4,5-dihydro-6H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-6-yl]-N-isopropylacetamide, an orally active, gut-selective CCK1 receptor agonist for the potential treatment of obesity

Richard L. Elliott, Kimberly O. Cameron, Janice E. Chin et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 30 citations · Full text

Metabolic Syndrome, Medicinal Chemistry, Biochemistry +9

Structure–activity relationship studies on 2-heteroaryl-4-arylimidazoles NPY5 receptor antagonists

Richard L. Elliott, Robert M. Oliver, Janet A. LaFlamme et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 26 citations · Full text

Molecular Pharmacology, Drug Target, Medicine +5

Structure–activity relationships in a series of NPY Y5 antagonists: 3-amido-9-ethylcarbazoles, core-modified analogues and amide isosteres

Marlys Hammond, Richard L. Elliott, Melissa L. Gillaspy et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 15 citations · Full text

Medicinal Chemistry, Npy Y5 Antagonists, Biochemistry +8